According to GlobalData’s medical device pipeline database, 26 Implantable Cardioverter Defibrillators (ICD) devices are in various stages of development globally. GlobalData’s report Implantable Cardioverter Defibrillators (ICD) provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 13 are in active development, while the remaining 13 are in an inactive stage of development. There are nine products in the early stages of development, and the remaining four are in the late stages of development.
An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart’s rhythm and delivers electric pulses if it detects an arrhythmia (irregular heartbeat) to restore the heart’s natural rhythm. ICDs contain three main components: a pulse generator, electrodes, and leads. However, the devices can also be leadless. Single Chamber ICD, Dual Chamber ICD and Subcutaneous ICD are tracked under this segment. One unit refers to One ICD device.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Implantable Cardioverter Defibrillators (ICD) pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Implantable Cardioverter Defibrillators (ICD) devices. Overall, most of these Implantable Cardioverter Defibrillators (ICD) pipeline devices are being developed by private entities.
Key players involved in the active development of Implantable Cardioverter Defibrillators (ICD) include MicroPort CRM, Boston Scientific, Massachusetts General Hospital, Max Planck Institute for Dynamics and Self-Organization, Medicool Technologies, Medtronic, Medtronic, Advanced BioInformatics, AIS and Arrhythmia Dynamics.
For a complete picture of the developmental pipeline for Implantable Cardioverter Defibrillators (ICD) devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.